A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib

Clinical trial NCT00513253 · WITHDRAWN

Trial details

NCT number: NCT00513253
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2008-04-01
Primary completion: 2008-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.